Chemomab Therapeutics (CMMB) EPS (Diluted) (2021 - 2026)
Chemomab Therapeutics (CMMB) recorded EPS (Diluted) of $0.34 in Q2 2026, down 25.9% from $0.46 a year earlier.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) EPS (Diluted) (2021 - 2026) Analysis & Trends
On a TTM basis, Chemomab Therapeutics' EPS (Diluted) came in at $0.63 as of Jun 30, 2026, down 45.6% year-over-year; for FY2025, it was $1.41, down 54.6% from FY2024.
- Annual EPS (Diluted) has declined for three straight years, with a four-year compound annual growth rate of -26.4% (FY2021 to FY2025).
- Across earlier years, EPS (Diluted) came in at $3.11 in FY2024 (-62.3%), $8.25 in FY2023 (-15.2%), $9.72 in FY2022 (+102.0%) and $4.81 in FY2021.
- Quarterly EPS (Diluted) has ranged from -$3.17 in Q1 2023 to $7.68 in Q4 2021 over the past five years.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 32.9% in Q2 2023, against a decline of 67.3% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$0.28 (Q1 2026), $0.29 (Q4 2025) and $0.39 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Chemomab Therapeutics | 11.80 Mn | 11.80 Mn | - | 0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.34 |
| Mar 31, 2026 | -0.28 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.46 |
| Mar 31, 2025 | -0.74 |
| Dec 31, 2024 | 0.66 |
| Sep 30, 2024 | 1.19 |
| Jun 30, 2024 | -1.24 |
| Mar 31, 2024 | -1.32 |
| Dec 31, 2023 | 1.16 |
| Sep 30, 2023 | 1.48 |
| Jun 30, 2023 | 2.89 |
| Mar 31, 2023 | -3.17 |
| Dec 31, 2022 | 2.91 |
| Sep 30, 2022 | 2.83 |
| Jun 30, 2022 | 2.17 |
| Mar 31, 2022 | -1.79 |
| Dec 31, 2021 | 7.68 |
| Sep 30, 2021 | -1.04 |
API Access
Chemomab Therapeutics EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();